Clindamycin Phosphate Topical Solution USP 1%
Company: Morton Grove Pharmaceuticals
Approval Status: Approved July 1997
Treatment for: acne vulgaris
Areas: Dermatology/Plastic Surgery
Possible similar drugs: Clindamycin phosphate topical gel
General Information
Other Useful Resources
Morton Grove Pharmaceuticals' Clindamycin Phosphate Topical Solution USP 1%, an antibiotic for the treatment of acne vulgaris, has been approved by the FDA. According to the FDA approval letter, Morton Grove Pharmaceuticals' product was found to be equivalent to CLEOCIN Topical Solution 1%, marketed by Pharmacia & Upjohn Company.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
